Arcutis Biotherapeutics, Inc. (ARQT)
23.97
-0.15
(-0.62%)
USD |
NASDAQ |
Mar 05, 16:00
23.84
-0.13
(-0.54%)
Pre-Market: 08:42
Arcutis Biotherapeutics Cash from Investing (TTM) : -30.25M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| CorMedix, Inc. | -- |
| ADMA Biologics, Inc. | -21.89M |
| ANI Pharmaceuticals, Inc. | -34.32M |
| Amicus Therapeutics, Inc. | -46.43M |
| Mirum Pharmaceuticals, Inc. | -23.95M |